FDA Designations Granted to PRAX-222, PRAX-562 for Epileptic Encephalopathies
Source: Pixabay.com

FDA Designations Granted to PRAX-222, PRAX-562 for Epileptic Encephalopathies

According to a recent press release from biopharmaceutical company Praxis Precision Medicines ("Praxis"), two of the company's drug candidates received either Orphan Drug or Rare Pediatric Disease designations for rare…

Continue Reading FDA Designations Granted to PRAX-222, PRAX-562 for Epileptic Encephalopathies
SUDEP Not as Rare as Once Believed, Could Cause 3% of Sudden Childhood Deaths
Source: www.pixabay.com

SUDEP Not as Rare as Once Believed, Could Cause 3% of Sudden Childhood Deaths

  Over the last decade, more information has been discovered about sudden unexpected death in epilepsy (SUDEP), although there is still much learning to be done. While researchers initially believed…

Continue Reading SUDEP Not as Rare as Once Believed, Could Cause 3% of Sudden Childhood Deaths
FDA Approves of Status Epilepticus Treatment, SESQUIENT
https://pixabay.com/en/approved-pass-ok-approval-symbol-1726357/

FDA Approves of Status Epilepticus Treatment, SESQUIENT

Sedor Pharmaceuticals, a partner of Ligand Pharmaceuticals, has recently received FDA approval for SESQUIENT, its status epilepticus treatment. It has been cleared for the treatment of both adult and pediatric…

Continue Reading FDA Approves of Status Epilepticus Treatment, SESQUIENT
Injectable XP-0863 for Acute Repetitive Seizures Given Fast Track Designation
https://pixabay.com/en/epilepsy-seizure-stroke-headache-623346/

Injectable XP-0863 for Acute Repetitive Seizures Given Fast Track Designation

Recently, specialty pharmaceutical company Xeris Pharmaceuticals ("Xeris") announced that its injectable treatment XP-0863 received Fast Track designation for the treatment of patients with acute repetitive seizures. Xeris created this treatment…

Continue Reading Injectable XP-0863 for Acute Repetitive Seizures Given Fast Track Designation
A Possible Treatment for CDKL5 Deficiency Disorder has Earned Rare Pediatric Disease Designation
source: pixabay.com

A Possible Treatment for CDKL5 Deficiency Disorder has Earned Rare Pediatric Disease Designation

According to a story from BioSpace, the pharmaceutical company Marinus Pharmaceuticals, Inc. announced recently that its investigational product candidate ganaxolone has earned Rare Pediatric Disease designation from the US Food…

Continue Reading A Possible Treatment for CDKL5 Deficiency Disorder has Earned Rare Pediatric Disease Designation
Uncovering the Cause of Sudden Aphasia in a Patient with Osteomyelitis: A Case Study
source: pixabay.com

Uncovering the Cause of Sudden Aphasia in a Patient with Osteomyelitis: A Case Study

  Want to learn more about recognizing symptoms and diagnosing patients? Well, now you can. In a MedPage article, authors encourage readers to follow along on a case study to…

Continue Reading Uncovering the Cause of Sudden Aphasia in a Patient with Osteomyelitis: A Case Study
Positive Findings in Phase 2 Study of Refractory Status Epilepticus Drug Candidate
TeroVesalainen / Pixabay

Positive Findings in Phase 2 Study of Refractory Status Epilepticus Drug Candidate

According to a recent press release from the Pennsylvania-based Marinus Pharmaceuticals, the Company is reporting positive results of its phase 2 study of "ganaxolone," an investigational GABAA modulator for patients…

Continue Reading Positive Findings in Phase 2 Study of Refractory Status Epilepticus Drug Candidate

A Nasal Spray Has Just Become the First New Therapy Approved by the FDA for Cluster Seizures in 20 Years

Cluster Seizures Approximately 1/3 of all epilepsy patients live with uncontrolled seizures. Of these, around 150,000 in the United States alone  experience cluster seizures (otherwise known as acute-repetitive seizures, crescendo…

Continue Reading A Nasal Spray Has Just Become the First New Therapy Approved by the FDA for Cluster Seizures in 20 Years
Ganaxolone Shows Potential in Treating CDKL5 and Reveals Biomarker in PCDH19 Epilepsy
stevepb / Pixabay

Ganaxolone Shows Potential in Treating CDKL5 and Reveals Biomarker in PCDH19 Epilepsy

According to a story from globenewswire.com, the biopharmaceutical company Marinus Pharmaceuticals, Inc., recently announced the presentation of Phase 2 clinical trial of the drug ganaxolone as a treatment for CDKL5…

Continue Reading Ganaxolone Shows Potential in Treating CDKL5 and Reveals Biomarker in PCDH19 Epilepsy
A Researcher is Looking Into How Long Artificial Comas Should Last For Status Epilepticus Patients
Bru-nO / Pixabay

A Researcher is Looking Into How Long Artificial Comas Should Last For Status Epilepticus Patients

A researcher from the University of Alabama at Birmingham is working on how to improve treatment for patients with status epilepticus. The original article can be read here, at UAB…

Continue Reading A Researcher is Looking Into How Long Artificial Comas Should Last For Status Epilepticus Patients

Editor’s Choice: It’s Junvenile Arthritis Awareness Month!

Happy Friday! How's the the sweltering heat treating you all (if you're on the east coast of the US, that is)? Hoping you are keeping cool! In the meantime, check out…

Continue Reading Editor’s Choice: It’s Junvenile Arthritis Awareness Month!
Why Status Epilepticus (SE) Drug Therapy Research is Hot News
https://pixabay.com/en/epilepsy-seizure-stroke-headache-623346/

Why Status Epilepticus (SE) Drug Therapy Research is Hot News

Has your healthcare provider ever talked to you about using an FDA-approved drug for an unapproved use (sometimes called an “off-label” use) to treat your disease or medical condition? It…

Continue Reading Why Status Epilepticus (SE) Drug Therapy Research is Hot News
Super-Refractory Status Epilepticus: Could a Ketogenic Diet Help?
https://pixabay.com/en/asparagus-green-green-asparagus-1307604/

Super-Refractory Status Epilepticus: Could a Ketogenic Diet Help?

Status epilepticus is a rare and sometimes fatal condition. About 60 percent of those with this super-refractory status epilepticus (SRSE) die, making it the most dangerous type of seizure. This…

Continue Reading Super-Refractory Status Epilepticus: Could a Ketogenic Diet Help?
Why is She Having a Difficult Time Accessing Marijuana for Seizures and Status Epilepticus?
https://pixabay.com/en/brown-marijuana-pot-stash-weed-20804/

Why is She Having a Difficult Time Accessing Marijuana for Seizures and Status Epilepticus?

Sarah Trask had childhood cancer 32 years ago and had four brain surgeries. Sarah is a survivor. As a result, epilepsy is the side effect she is living with. Sometimes…

Continue Reading Why is She Having a Difficult Time Accessing Marijuana for Seizures and Status Epilepticus?
If Your Child Had a Status Epilepticus Situation, Would You Know?
https://pixabay.com/en/toddler-boy-sleeping-child-1245674/

If Your Child Had a Status Epilepticus Situation, Would You Know?

Any parent watching their child have an epileptic seizure can tell you that even the shortest seizure seems to last forever. In the case of a seizure that goes on for…

Continue Reading If Your Child Had a Status Epilepticus Situation, Would You Know?
Clobazam: Why There Might Be Real Hope for Status Epilepticus!
[Source: Pixabay.com]

Clobazam: Why There Might Be Real Hope for Status Epilepticus!

Status epilepticus (SE) is a serious, problematic, frightening, and often fatal condition, relating to uncontrolled seizures that continue to happen without any type of recovery between the seizures. SE is a…

Continue Reading Clobazam: Why There Might Be Real Hope for Status Epilepticus!